Polyscias fruticosa (L.) Harms as a Functional Botanical Resource: A Quality-Gated Framework Linking Phytochemistry, Extraction Engineering, Bioactivity, and Application-Specific Development

Polyscias fruticosa (L.) Harms is consumed as food and used traditionally in Southeast Asia, but reproducible ingredient development requires the alignment of raw material identity, chemical specification, processing, exposure, safety, and claims. This critical narrative review integrates species-specific studies with analytical, engineering, and regulatory considerations within a five-stage translational framework, with safety considered throughout. Findings support P. fruticosa saponin as a candidate quantitative anchor alongside complementary markers and document laboratory extraction optimization, mechanism-linked cellular responses, and animal proof-of-concept studies. However, direct biological studies remain predominantly preclinical, while bioaccessibility, pharmacokinetics, metabolite profiling, tissue distribution, target engagement, and controlled human validation remain limited or absent. Animal studies also report reproductive and gestational safety findings that warrant product-specific evaluation of concentrated or repeated-exposure materials. Credible scale-up requires predefined specifications, delivered-energy characterization, solvent recovery, and process designs that preserve product quality. Stronger physiological or therapeutic claims require substantiation through release, exposure, stability, efficacy, and safety data. The literature supports application-specific development of P. fruticosa for food, nutraceutical, topical, and pharmaceutical products, with claim strength constrained by the least validated element across material identity, specification, processing, exposure, safety, and finished product performance. This framework distinguishes reported findings from transferable guidance and identifies priorities for reproducible development.